Shares of Solventum Co. (NYSE:SOLV – Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 1,781,491 shares were traded during trading, an increase of 82% from the previous session’s volume of 978,943 shares.The stock last traded at $68.66 and had previously closed at $69.41.
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on SOLV. Stifel Nicolaus started coverage on Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price objective for the company. Piper Sandler upped their price target on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Morgan Stanley raised their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Mizuho initiated coverage on shares of Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. Finally, Wolfe Research initiated coverage on shares of Solventum in a research report on Thursday, September 26th. They set a “peer perform” rating for the company. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $68.29.
Read Our Latest Analysis on SOLV
Solventum Price Performance
Institutional Trading of Solventum
Several large investors have recently added to or reduced their stakes in SOLV. Copeland Capital Management LLC bought a new stake in Solventum during the 3rd quarter worth approximately $26,000. Modus Advisors LLC purchased a new stake in shares of Solventum during the fourth quarter worth about $25,000. Mather Group LLC. bought a new stake in Solventum during the 3rd quarter valued at approximately $27,000. Hollencrest Capital Management bought a new stake in Solventum during the 2nd quarter valued at approximately $25,000. Finally, True Wealth Design LLC lifted its holdings in Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after purchasing an additional 471 shares in the last quarter.
Solventum Company Profile
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Recommended Stories
- Five stocks we like better than Solventum
- How to Calculate Return on Investment (ROI)
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What Are Dividend Contenders? Investing in Dividend Contenders
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Find and Profitably Trade Stocks at 52-Week Lows
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.